Orgenesis Inc: Top-Line Efficacy and Safety Data From Study Had a Complete Response (Cr )of 82% in Adult Patients and 93% in Pediatric Patients
Orgenesis 公司:該研究的頂線療效和安全性數據顯示,在成人患者中完全緩解率爲82%,在兒科患者中爲93%。
Orgenesis Inc: Top-Line Efficacy and Safety Data From Study Had a Complete Response (Cr )of 82% in Adult Patients and 93% in Pediatric Patients
Orgenesis 公司:該研究的頂線療效和安全性數據顯示,在成人患者中完全緩解率爲82%,在兒科患者中爲93%。
譯文內容由第三人軟體翻譯。